PATENT CLAIM ANALYSIS

Application Number: 16042534
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-05
Patent Classification: ["424", "489000"]

Abstract:
The present invention relates to methods and compositions for anti-aging therapy and for the treatment and prophylaxis of age-related diseases and disorders in a human subject in need of such therapy or treatment, the methods comprising the pulmonary administration to the subject, preferably via inhalation, of composition comprising rapamycin, or a prodrug or derivative thereof.

Claim (Index 44):
A method for treating a chronic lung disease or disorder in geriatric human subject in need thereof, the method comprising administering to the subject a pharmaceutical composition in the form of an inhalable dry powder comprising microparticles of rapamycin, particles of a carrier, and one or more optional excipients, wherein the composition is administered to the subject once daily by inhalation and the total daily dose of rapamycin administered is from 20 to 500 micrograms.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 95.0
- Lexical Diversity: 1.57895
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15028365', '15803005', '11726813', '13530025', '13874405']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7480395816329855
- 35 USC 102 Novelty (BERT): 0.5238250603924067
- Combined Prediction Score: 0.7256181295089276
- Mean Citation Score: 249.893826
- Max Citation Score: 337.20328
- Similarity Product: 223.68720790279392

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test